2Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, Evanston, Illinois. 3Robert H. Lurie Comprehensive Cancer Center ...
Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
Cancer Res (2023) 83 (8_Supplement): LB215.
1Yonsei University, College of Medicine, Seoul, Republic of Korea.
1Adult Stem Cell Research Center and Research Institute for Veterinary Science, Seoul, Republic of Korea.
The discovery and characterization of novel WRN helicase inhibitors provides pharmacological validation for the clinical development of WRN inhibitors for the treatment of patients with MSI tumors.
1Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels, Belgium. 2Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
SEMA3G binding to NRP1 suppresses cytotoxic T-cell activity to induce an immunosuppressive tumor microenvironment, positioning SEMA3G as a promising therapeutic target for improving cancer ...
Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), ...
1Basser Center for BRCA1/2, University of Pennsylvania, Philadelphia, Pennsylvania. 2Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results